Cell & gene therapy
An agentic platform that automates ATC readiness assessment, gap tracking, and activation planning — so manufacturers and treatment centers stay aligned from qualification through first infusion.
Capabilities, CGT portfolio, accreditation, REMS — captured once, reused for every launch.
FACT (Adult, Pediatric, IEC, Cord Blood), JACIE, ISBT 128, AABB. Tracked with expirations.
Manufacturers configure requirements; ATCs see their gaps and an ETA to close them.
AI agents continuously score readiness, surface at-risk activities, and generate activation plans aligned to PDUFA.